Precision Medicine News and Research

RSS

Points to consider: Should germline genetic testing be offered to all patients with breast cancer?

Should germline genetic testing be offered to all patients with breast cancer? The American College of Medical Genetics and Genomics addresses this important question in a new statement published in Genetics in Medicine, "Points to Consider: Is There Evidence to Support BRCA1/2 and Other Inherited Breast Cancer Genetic Testing for All Breast Cancer Patients? A Statement of the American College of Medical Genetics and Genomics."

13 Dec 2019

Rice University study aims to clarify microscopic aspects of cancer initiation

When do cancer-prone cells turn into full-blown cancer? A Rice University scientist and his colleague believe there's a way to know.

12 Dec 2019

Radiation therapy alone found to be cost-effective for treatment of DCIS

Ductal carcinoma in-situ (DCIS) accounts for one-fifth of breast cancer cases in the United States, according to the American Cancer Society.

11 Dec 2019

Gut disease and gene analysis networks

Gut diseases are difficult to diagnose in many cases, and their underlying dysfunction is hard to understand in many cases. Now, a new study published in the journal Molecular Omics promises to uncover a better insight into how these conditions occur and their mechanisms, by providing a deeper look at how genes interact in complex ways in health and fail to do so in disease.

11 Dec 2019

UIC researchers to study the impact of chronic eye disease among Latinos

With $9.7 million in funding from the National Eye Institute, researchers at the University of Illinois at Chicago will study the impact of chronic eye disease among Latinos.

10 Dec 2019

A network approach to explore the causes of IBD

Diseases of the gut are often notoriously difficult to diagnose, nevermind understand, which is where a network-based approach comes in.

10 Dec 2019

Experts publish new book with recommendations to reduce Latino cancer

As U.S. Latinos face a staggering 142% projected rise in cancer cases by 2030, UT Health San Antonio leaders gathered international cancer experts to publish a new book with innovative research and recommendations to reduce Latino cancer.

9 Dec 2019

Study identifies genetic variation linked to heart failure risk in people of African, Latino ancestry

A genetic variation believed to increase risk for heart failure in people of African or Latino ancestry has been identified in a new study by researchers from the Icahn School of Medicine at Mount Sinai and Perelman School of Medicine at the University of Pennsylvania.

9 Dec 2019

UM Medicine launches new centers in Maryland to treat adults with neurodevelopmental disabilities

The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.

8 Dec 2019

New technique holds promise in cancer research and science studies

A new technique reported this week in Science overcomes several limitations of typical high-throughput chemical screens conducted on cell samples. Such screens are commonly used to try to discover new cancer drugs, and in many other biomedical applications.

8 Dec 2019

Innovative consortium will provide access to newest clinical trials and medical breakthroughs

New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.

8 Dec 2019

Researchers identify a missed opportunity in the treatment of ER+ breast cancers

In the United States, apart from some forms of skin cancer, breast cancer is the most common cancer in women. It is also the most common cause of death from cancer among Hispanic women and the second most common among all other women, after lung cancer.

6 Dec 2019

Evergreen Life spearheads the drive for everyone to have access to personal health data

Recent media reports have focused on the prospect that US businesses may want to buy patient data from the NHS.

From Evergreen Life 6 Dec 2019

Mologic starts major clinical trial to validate point-of-care COPD exacerbation alert system

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it has started a major clinical trial to validate the Company’s urine-based multi-biomarker self-test, Headstart, for the early detection of exacerbations in patients living with moderate to severe Chronic Obstructive Pulmonary Disease .

6 Dec 2019

Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

Shoghag Panjarian, PhD, a research scientist at the Coriell Institute for Medical Research, has been awarded a grant from the W. W. Smith Charitable Trust to support her search for epigenetic factors that contribute to the development and growth of breast cancer.

5 Dec 2019

ADDF announces new awards through its Diagnostics Accelerator initiative

The Alzheimer's Drug Discovery Foundation announced six new investments totaling $6 million through its Diagnostics Accelerator initiative.

4 Dec 2019

Epigenomic techniques used to fight disease

Humans differ from one another in many ways, including how they react to disease, because of their DNA blueprint, as well as the difference in the environments they face. These factors combine to make each person unique. Now a new study published in the journal Nature Protocols reports the development of a promising technology to uncover the process by which the body fights diseases in different ways.

4 Dec 2019

GW-led consortium receives $2.2 million from FDA for Biocompute Object Specification Project

A consortium led by the George Washington University (GW) has been refunded for their BioCompute Object Specification Project, thanks to a $2.2 million, five-year grant from the U.S. Food and Drug Administration.

4 Dec 2019

FDA-approved drug repairs gut leakiness associated with ulcerative colitis

A research team led by biomedical scientists at the University of California, Riverside, has found that a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis can repair permeability defects in the gut's epithelium.

4 Dec 2019

Researchers create new technology to help understand how the body battles diseases

Much remains unknown about diseases and the way our bodies respond to them, in part because the human genome is the complete DNA assembly that makes each person unique. A Virginia Tech professor and his team of researchers have created new technology to help in understanding how the human body battles diseases.

3 Dec 2019

Precision Medicine News and Research

Points to consider: Should germline genetic testing be offered to all patients with breast cancer?

Rice University study aims to clarify microscopic aspects of cancer initiation

Radiation therapy alone found to be cost-effective for treatment of DCIS

Gut disease and gene analysis networks

UIC researchers to study the impact of chronic eye disease among Latinos

A network approach to explore the causes of IBD

Experts publish new book with recommendations to reduce Latino cancer

Study identifies genetic variation linked to heart failure risk in people of African, Latino ancestry

UM Medicine launches new centers in Maryland to treat adults with neurodevelopmental disabilities

New technique holds promise in cancer research and science studies

Innovative consortium will provide access to newest clinical trials and medical breakthroughs

Researchers identify a missed opportunity in the treatment of ER+ breast cancers

Evergreen Life spearheads the drive for everyone to have access to personal health data

Mologic starts major clinical trial to validate point-of-care COPD exacerbation alert system

Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

ADDF announces new awards through its Diagnostics Accelerator initiative

Epigenomic techniques used to fight disease

GW-led consortium receives $2.2 million from FDA for Biocompute Object Specification Project

FDA-approved drug repairs gut leakiness associated with ulcerative colitis

Researchers create new technology to help understand how the body battles diseases

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News